Robert Eckelr
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Lipid metabolism and disorders
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 43
-
- Lipid metabolism and disorders 46
- Co-authors
- Alice Hinda Lichtenstein (4 shared papers)Neil J. Stone (4 shared papers)Jennifer G. Robinson (3 shared papers)Peter Wyman Ford Wilson (3 shared papers)Daniel Levy (2 shared papers)Patrick E. McBride (2 shared papers)Donald M. Lloyd‐Jones (2 shared papers)J. Sanford Schwartz (2 shared papers)
- Journals
- Circulation (18 papers)Diabetes (11 papers)Journal of Lipid Research (11 papers)Metabolism (7 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Robert Eckelr
181 papers receiving 30.9k citations
Robert Eckelr's Hit Papers
Peers
Comparison fields: 5 of 196
- Endocrinology, Diabetes and Metabolism 5.9k
- Cardiology and Cardiovascular Medicine 7.0k
- Surgery 8.8k
- Physiology 5.2k
- Biochemistry 1.2k
Countries citing papers authored by Robert Eckelr
This map shows the geographic impact of Robert Eckelr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Eckelr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Eckelr more than expected).
Fields of papers citing papers by Robert Eckelr
This network shows the impact of papers produced by Robert Eckelr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Eckelr. The network helps show where Robert Eckelr may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Eckelr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Hit paper breakdown → | 2013 | 6147 |
| 2 | 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Hit paper breakdown → | 2013 | 3297 |
| 3 | Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss Hit paper breakdown → | 2005 | 2558 |
| 4 | 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk Hit paper breakdown → | 2013 | 1913 |
| 5 | AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update Hit paper breakdown → | 2002 | 1512 |
| 6 | Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement Hit paper breakdown → | 2019 | 1127 |
| 7 | Lipoprotein Lipase Hit paper breakdown → | 1989 | 877 |
| 8 | Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat Hit paper breakdown → | 2000 | 773 |
| 9 | Lipoprotein lipase: from gene to obesity Hit paper breakdown → | 2009 | 693 |
| 10 | American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease Hit paper breakdown → | 1998 | 658 |
| 11 | Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain Hit paper breakdown → | 2013 | 648 |
| 12 | New-Onset Diabetes in Covid-19 Hit paper breakdown → | 2020 | 611 |
| 13 | Progress and Challenges in Metabolic Syndrome in Children and Adolescents Hit paper breakdown → | 2009 | 602 |
| 14 | Statin Toxicity Hit paper breakdown → | 2019 | 595 |
| 15 | Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk Hit paper breakdown → | 2022 | 517 |
| 16 | Treatment of Obesity Hit paper breakdown → | 2016 | 482 |
| 17 | 2002 | 441 | |
| 18 | Type 1 Diabetes Mellitus and Cardiovascular Disease Hit paper breakdown → | 2014 | 431 |
| 19 | 2008 | 355 | |
| 20 | 2002 | 315 |
About Robert Eckelr
Robert Eckelr is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Physiology, Surgery and Biochemistry, having authored 185 papers that have together received 32.4k indexed citations. Recurring topics across this work include Lipid metabolism and disorders (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (43 papers), Lipoproteins and Cardiovascular Health (29 papers), Adipose Tissue and Metabolism (25 papers), Diet and metabolism studies (23 papers), Pharmacology and Obesity Treatment (18 papers), Lipid metabolism and biosynthesis (15 papers) and Cholesterol and Lipid Metabolism (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.9k citations), Cardiology and Cardiovascular Medicine (7.0k citations), Surgery (8.8k citations), Physiology (5.2k citations) and Biochemistry (1.2k citations). Robert Eckelr has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Alice Hinda Lichtenstein, Neil J. Stone, Jennifer G. Robinson, Peter Wyman Ford Wilson, Daniel Levy, Patrick E. McBride, Donald M. Lloyd‐Jones, J. Sanford Schwartz, David Gordon and Conrad B. Blum. Their work appears in journals such as Circulation, Diabetes, Journal of Lipid Research, Metabolism and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.